Validation Of The HAS-BLED Tool In Atrial Fibrillation Patients Receiving Rivaroxaban
{{output}}
Background: Atrial fibrillation (Afib) patients are at an increased risk of stroke. Patients at moderate to high risk of stroke typically receive antithrombotics, placing them at an increased risk of bleeding. The HAS-BLED tool has been validated in Afib patie... ...
